# Indivior PLC Enters into Agreement with Alvogen

- Link: https://www.directorstalkinterviews.com/indivior-plc-enters-into-agreement-with-alvogen/412766256
- Published: 2019-02-04T07:39:23+00:00
- Author: Charlotte Edwards

**Indivior PLC** (LON: INDV) today announced that it has entered into an agreement
with Alvogen Pine Brook LLC, enjoining Alvogen from the use, offer to sell, or sale
within the United States, or importation into the United States, of its generic 
buprenorphine and naloxone sublingual film product unless and until the United States
Court of Appeals for the Federal Circuit (CAFC) issues a mandate vacating the preliminary
injunction against Dr. Reddy’s Laboratories (DRL) previously granted by the U.S.
District Court for the District of New Jersey on July 13, 2018.

Indivior had been granted a Temporary Restraining Order (TRO) by the U.S. District
Court for the District of New Jersey against Alvogen on January 24, 2019, and the
court had scheduled a preliminary injunction (PI) hearing for February 7, 2019. 
As a result of this agreement, the PI hearing will not take place.

> **Shaun Thaxter, CEO of Indivior, said** “We are pleased to have reached an agreement
> with Alvogen with respect to the PI. Indivior will continue to pursue its infringement
> cases against Alvogen, including the appeal of the U.S. District Court for the
> District of Delaware’s non-infringement decision related to U.S. patent 8,603,514,
> as well as the District Court litigation of our more recently listed Orange Book
> patents for SUBOXONE® Film.”

Share on:
